Actively Recruiting
Long-Term Safety and Clinical Outcomes Evaluation of Livmarli in Patients with Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the United States
Led by Mirum Pharmaceuticals, Inc. · Updated on 2026-10-08
70
Participants Needed
8
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the long-term safety and clinical outcomes of patients with Alagille syndrome ALGS or Progressive familial intrahepatic cholestasis PFIC who are treated with Livmarli. The study is a prospective observational cohort lasting five years, focusing on patients who have a confirmed diagnosis of ALGS or PFIC and are prescribed Livmarli. Livmarli is a novel, minimally absorbed drug that reduces bile acid levels by inhibiting the ileal bile acid transporter and is FDA-approved for treating cholestatic pruritus in these patients. Participants prescribed Livmarli will be observed over five years, with the drug administered at recommended dosages of either 380 mcgkg once daily or 570 mcgkg twice daily. The study includes groups with ALGS or PFIC diagnoses, both prescribed Livmarli, to assess safety and clinical outcomes without altering treatment. The observational design means participants will continue their prescribed Livmarli regimen as part of routine care. During the study, researchers will record long-term clinical outcomes such as liver transplant indications, waitlist status, growth and development measurements, and clinical events related to fat-soluble vitamin deficiencies. Data collection will occur at enrollment and at regular intervals, including every six months and annually for five years. This study excludes participants who have received prior liver surgeries or investigational drugs recently and monitors safety up to 180 days after discontinuing Livmarli.
CONDITIONS
Brief Title
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)
Research Team
C
Clinical Trials Mirum
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here